Adamas Pharmaceuticals Inc ADMS Income Statement

Adamas pharmaceuticals inc (ADMS)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Revenues:
Total revenues
0	-	-	-	0	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product sales
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total net revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,059	1,689	1,865	1,916	31,693	31,140	55,896	55,846	65,655	65,601	40,688	71,095	0	0	0
Costs and operating expenses:
Cost of product sales
2,628	2,469	2,462	1,633	1,021	633	198	98	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of product sales
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
22,285	30,034	35,451	41,118	42,326	39,300	35,148	29,898	27,268	27,168	27,770	28,748	30,796	31,230	33,880	36,403	35,884	35,895	34,715	30,167	26,635	21,860	15,716	11,691	8,090	7,410	0	0	0
Selling, general and administrative, net
111,233	114,369	111,666	107,977	110,460	109,135	104,542	93,115	78,531	61,312	45,667	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total costs and operating expenses
136,146	146,872	149,579	150,728	153,807	149,068	132,977	113,968	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27,392	25,180	-	21,316	19,866	17,282	15,472	13,337	10,555	8,656	6,667	0	0	0
Total costs and operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	63,625	-	62,813	63,795	61,064	59,353	56,031	50,033	43,917	37,332	29,053	22,246	16,746	14,077	0	0	0
Loss from operations
-78,693	-92,235	-97,975	-102,444	-110,649	-115,022	-118,606	-112,441	-102,717	-87,926	-74,336	-66,457	-63,228	-60,984	-61,754	-62,106	-59,199	-57,437	-24,338	-18,893	11,979	18,514	36,602	43,355	23,942	57,018	0	0	0
Interest and other income, net
-1,454	-2,093	-2,153	-2,562	-2,960	-3,115	-3,017	-2,935	-2,025	-1,351	-1,483	-893	-855	-811	-691	-527	-445	-363	-149	-63	151	917	0	0	0	-	-	-	-
Interest expense
14,937	15,044	15,172	16,682	17,997	19,092	17,563	13,854	9,471	4,645	2,406	729	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Other income (expense), net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Loss before income taxes
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-57,074	-24,189	-18,830	11,828	17,597	32,309	38,637	18,769	52,112	0	0	0
Benefit for income taxes
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-5,272	7,192	7,249	7,427	7,374	873	1,083	997	1,191	0	0	0
Net loss
-92,176	-105,186	-110,994	-116,564	-125,686	-130,999	-131,473	-121,681	-108,433	-89,490	-75,093	-66,127	-62,258	-60,058	-55,788	-56,253	-53,428	-51,802	-31,381	-26,079	4,401	10,223	31,436	37,554	17,772	50,921	0	0	0
Basic
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	33,068	0	0	0
Diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	35,353	0	0	0
Basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.69	0.79	-0.57	1.05	-0.67	2.33	-0.36	-0.35	1.86
Diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.69	0.89	-0.57	0.88	-0.67	2.00	-0.36	-0.35	1.70
Net loss per share, basic and diluted (in dollars per share)
-0.59	-0.83	-0.99	-0.90	-1.08	-1.04	-1.22	-1.26	-1.35	-1.28	-1.04	-0.93	-0.72	-0.68	-0.66	-0.78	-0.65	-	-0.81	-0.78	-	-	-	-	-	-	-	-	-
Basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17,643	17,432	16,787	15,604	9,525	9,512	9,510	9,506	9,496
Diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	17,643	23,526	16,787	18,590	9,525	17,410	9,510	9,506	10,798
Weighted average shares used in computing net loss per share, basic and diluted (in shares)
28,030	27,898	27,778	27,579	27,453	27,377	27,266	27,040	25,861	23,065	22,569	22,392	22,206	22,000	21,941	21,650	21,253	-	18,395	17	-	-	-	-	-	-	-	-	-
Product sales
Total revenues
-	-	51,604	48,284	-	34,046	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-